StockDrifts LogoStockDrifts

Lion Point Capital LP

Portfolio Manager
Lion Point Capital LP
Performance
-11.40% (2026 Q1)
AUM (13F)
$16.73M
# of Holdings
35
Performance Rank
Allocation (Top 20)
80.01%

Lion Point Capital LP Holdings Map

Top 35 Lion Point Capital LP Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
PRAX
PRAXIS PRECISION MEDICINES I
8.57%4.5K$1.4M
+0.00%(+0)
2025-Q1: 0 shares2025-Q2: 0 shares2025-Q3: 5.7K shares2025-Q4: 4.5K shares2026-Q1: 4.5K shares
$47.52(+570.22%)
2026-03-31
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
7.52%67.5K$1.3M
+0.00%(+0)
2025-Q1: 0 shares2025-Q2: 0 shares2025-Q3: 67.5K shares2025-Q4: 67.5K shares2026-Q1: 67.5K shares
$27.19(-30.29%)
2026-03-31
RPRX
ROYALTY PHARMA PLC
6.14%21.4K$1.0M
+0.00%(+0)
2025-Q1: 0 shares2025-Q2: 0 shares2025-Q3: 21.4K shares2025-Q4: 21.4K shares2026-Q1: 21.4K shares
$35.65(+62.02%)
2026-03-31
MIST
MILESTONE PHARMACEUTICALS IN
5.83%820.0K$976K
+8.61%(+65.00K)
2025-Q1: 548.8K shares2025-Q2: 548.8K shares2025-Q3: 658.6K shares2025-Q4: 755.0K shares2026-Q1: 820.0K shares
$2.65(-50.22%)
2026-03-31
GERN
GERON CORP
5.15%578.0K$861K
+0.00%(+0)
2025-Q1: 500.0K shares2025-Q2: 500.0K shares2025-Q3: 500.0K shares2025-Q4: 578.0K shares2026-Q1: 578.0K shares
$2.57(-46.99%)
2026-03-31
SNDX
SYNDAX PHARMACEUTICALS INC
5.03%36.0K$841K
+0.00%(+0)
2025-Q1: 55.0K shares2025-Q2: 55.0K shares2025-Q3: 55.0K shares2025-Q4: 36.0K shares2026-Q1: 36.0K shares
$20.82(+4.81%)
2026-03-31
ARDX
ARDELYX INC
4.61%128.7K$771K
+0.00%(+0)
2025-Q1: 335.4K shares2025-Q2: 335.4K shares2025-Q3: 162.8K shares2025-Q4: 128.7K shares2026-Q1: 128.7K shares
$1.85(+185.04%)
2026-03-31
FENC
FENNEC PHARMACEUTICALS INC
4.13%112.4K$691K
+0.00%(+0)
2025-Q1: 195.7K shares2025-Q2: 195.7K shares2025-Q3: 123.0K shares2025-Q4: 112.4K shares2026-Q1: 112.4K shares
$8.73(+22.62%)
2026-03-31
BNTC
BENITEC BIOPHARMA INC
3.95%62.0K$660K
+0.00%(+0)
2025-Q1: 62.0K shares2025-Q2: 62.0K shares2025-Q3: 62.0K shares2025-Q4: 62.0K shares2026-Q1: 62.0K shares
$9.14(+44.70%)
2026-03-31
SRPT
SAREPTA THERAPEUTICS INC
3.71%28.5K$620K
+0.00%(+0)
2025-Q1: 0 shares2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 28.5K shares2026-Q1: 28.5K shares
$20.40(-5.47%)
2026-03-31

Unlock alerts, watchlists & AI chat

Sign up free to track Lion Point Capital LP, compare funds side by side, and get alerts the moment positions change.

More 13F analyses

View all